M&A Deal Summary

Fresenius Kabi USA Acquires Akorn

On April 24, 2017, Fresenius Kabi USA acquired life science company Akorn for 4.3B USD

Acquisition Highlights
  • This is Fresenius Kabi USA’s 1st transaction in the Life Science sector.
  • This is Fresenius Kabi USA’s largest (disclosed) transaction.
  • This is Fresenius Kabi USA’s 2nd transaction in the United States.
  • This is Fresenius Kabi USA’s 1st transaction in Illinois.

M&A Deal Summary
Date 2017-04-24
Target Akorn
Sector Life Science
Buyer(s) Fresenius Kabi USA
Deal Type Add-on Acquisition
Deal Value 4.3B USD
Advisor(s) J.P. Morgan Securities (Financial)
Cravath, Swaine & Moore
Polsinelli PC (Legal)

Target

Akorn

Lake Forest, Illinois, United States
Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Akorn, Inc. was founded in 1971 and is based in Lake Forest, Illinois.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Fresenius Kabi USA

Schaumburg, Illinois, United States
Category Company
Founded 1996
Sector Medical Products
DESCRIPTION

Fresenius Kabi USA LLC is a health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients inside and outside the hospital.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (Illinois) 1 of 1
Country (United States) 2 of 3
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-08 BD Rx business

Wilson, North Carolina, United States

BD Rx business is a pharmaceutical manufacturing plant developer of medical products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-31 Ivenix

North Andover, Massachusetts, United States

Ivenix is a medical technology company with a vision to eliminate infusion-related patient harm. The company was founded to develop innovative solutions that transform infusion delivery. Ivenix designed an infusion system from the ground up to streamline medication delivery and bring infusion technology into the digital age.

Buy -
Mergr

Product

Company

Legal